R And G Pharmastudies Co
R And G Pharmastudies Co., a prominent player in the pharmaceutical research and development sector, is headquartered in China (CN) and operates extensively across Asia and Europe. Founded in 2005, the company has established itself as a leader in drug formulation and clinical trial services, focusing on innovative solutions that enhance patient outcomes. With a diverse portfolio that includes contract research, regulatory affairs, and pharmacovigilance, R And G Pharmastudies Co. distinguishes itself through its commitment to quality and compliance. The company has achieved significant milestones, including partnerships with major pharmaceutical firms and successful product launches that underscore its market position. Renowned for its expertise and reliability, R And G Pharmastudies Co. continues to drive advancements in the pharmaceutical industry, making it a trusted name among clients and stakeholders alike.
DitchCarbon Score
How does R And G Pharmastudies Co's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Other Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
R And G Pharmastudies Co's score of 20 is higher than 82% of the industry. This can give you a sense of how well the company is doing compared to its peers.
R And G Pharmastudies Co's reported carbon emissions
R And G Pharmastudies Co, headquartered in China, currently does not report any specific carbon emissions data. However, the company has made significant climate commitments by pledging to achieve net-zero emissions across all scopes by 2050. This commitment was formalised in 2023, indicating a long-term strategy to address climate change and reduce their carbon footprint. As part of their climate strategy, R And G Pharmastudies Co is aligned with the Science Based Targets initiative (SBTi), which underscores their dedication to scientifically grounded climate action. The company is actively working towards these targets, although specific near-term reduction goals have not been disclosed. In summary, while R And G Pharmastudies Co has not provided detailed emissions data, their commitment to net-zero emissions by 2050 reflects a proactive approach to sustainability and climate responsibility within the professional services sector.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
R And G Pharmastudies Co is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
